Clinical Trial Supply USA

September 17 - 19, 2014

Crowne Plaza Boston - Newton, Boston, Massachusetts



Sponsors & Exhibitors
Media Partners

FEATURED CONTENT

Clinical Trial Supply & Logistics Insights 2014 -Interactive vBook
In this new Clinical Trial Supply &Logistics Insights 2014 Interactive vBook, Cold Chain IQ brings you 5 video insights from experts in the field. In this easily digestible interactive video eBook, find out how your peers are overcoming the greatest challenges and mitigating risk in the clinical supply chain.

Prepare, Prepare, Prepare - Lindsay Pinnick on International Clinical Supply
Clinical trial supply is a complicated enough business, but working internationally can really complicate matters. Read Pharma IQ's interview with Lindsay Pinnick, Clinical Supply Manager at UCB, who spoke to us about how to deal with the difficult issues which surround international supply.

Infographic: Clinical Trial Supply USA
Nearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. Read about this and more in our latest infographic exploring the latest trends in clinical trial supply.

Join the conversation

Clinical Trial Supply Europe Summit Highlights

Download the Agenda

Download the Agenda

Get involved in CTS USA 2014!

Sign up Now

Resource Center

Featured Downloads

InfographicsInfographics

  • Infographic: Clinical Trial Supply USAInfographic: Clinical Trial Supply USA

    Nearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. Read about this and more in our latest infographic exploring the latest trends in clinical trial supply.

PDFPDF

  • A 101 Guide to Qualified Person (QP) Release in Clinical Trial SupplyA 101 Guide to Qualified Person (QP) Release in Clinical Trial Supply
    Understanding pharmaceutical legislation is vital for successfully navigating the complex global clinical trials market and ensuring the timely supply of your Investigational Medicinal Products (IMPs). In Europe the Qualified Person (QP) plays a crucial role in bringing safe and timely products to the market. In this Pharma IQ 101 we highlight role of a Qualified Person in clinical trial supply management and the regulations you need to know. 

Additional Content Download

PDF

Comparator Sourcing

Articles

  • Tracking trial Cost drivers: The Impact of Comparator Drugs & Co-TherapiesTracking trial Cost drivers: The Impact of Comparator Drugs & Co-Therapies
    Drug Supply professionals concur that the increasing the sue of comparator drugs and co-therapies in clinical studies acts as a strong counter to company efforts to rein in the rapid growth in drug development spending. TransCelerate Biopharma, a consortium of 10 Big Pharma companies has committed to improving the overall costs and incidence of comparator drugs and co-therapies in clinical trials.
    By Mary Jo Lamberti, Terry Walsh, Kenneth Getz
  • The Trials and Tribulations of Comparator Sourcing for Clinical Trial MaterialsThe Trials and Tribulations of Comparator Sourcing for Clinical Trial Materials
    Once an appropriate comparator drug has been identified for use in a trial attention turns to how to source it. This may sound like a simple task but increasing globalization of the clinical research sector coupled with the frequent requirement to purchase a competitor’s product, make it more complex. This new Pharma IQ article reviews the key challenges associated with comparator sourcing of clinical trials materials and ways to reduce the risks associated with this task.

  • Clinical trial supply in Small Pharma and BiotechsClinical trial supply in Small Pharma and Biotechs
    In a rapidly evolving clinical trial supply landscape effectively planning and executing a successful clinical supply chain is no easy task. Ricardo Lima from Bial gives us his unique insight in the life of a smaller company in planning and managing their clinical trial supply.

  • Supply Chains Still the Biggest Issue When Sourcing Comparators for TrialsSupply Chains Still the Biggest Issue When Sourcing Comparators for Trials

    With healthcare's growing emphasis on the comparative effectiveness of new drugs in relation to what is already available, recent times have brought forth an expectation for developers to prove additional benefits at the clinical trial stage. But with more and more studies being conducted on a global scale, the process of sourcing comparators is fraught with difficulty.

  • Marken: Triangle Partnerships between Pharma, CROs & Supply Chain OrganisationsMarken: Triangle Partnerships between Pharma, CROs & Supply Chain Organisations

    As pharma companies have a mandate to reduce costs and look to optimise their supply chains globally and ensure that patients receive drugs on time, Ariette Van Strien, Senior VP, Commercial Operations at Marken, spoke to Pharma IQ about the new GDP guidelines for regulations will mean to the Pharma industry.

  • Managing Relationships in Clinical Trial Supply- Doug MeyerManaging Relationships in Clinical Trial Supply- Doug Meyer

    In this podcast, Doug Meyer Senior Manager of Process Optimization & Effectiveness Clinical Drug Supply at Biogen Idec. describes the managerial challenges involved in managing a portfolio of clinical supply chain process improvements.

Clinical Labelling & Packaging

Podcasts

Video

  • Drive Successful Commercial Product Launches through Effective Key PackagingDrive Successful Commercial Product Launches through Effective Key Packaging

    Effective packaging can help you increase profits, gain a bigger market share and better serve your customers. We know that your time is precious, so we've put together a webinar with some key industry experts to share their knowledge on ensuring product integrity throughout the supply chain and a pharma case study from Vertex pharmaceuticals.

Forecasting & Efficiency

Podcasts

  • Logistics, Planning & Forecasting and Improving Stakeholder Relationships: Hot Topics at CTS 2013Logistics, Planning & Forecasting and Improving Stakeholder Relationships: Hot Topics at CTS 2013

    Pharma IQ spoke to Steve Jacobs, President Global BioPharm Solutions and the Chair of Clinical Trial Supply Europe 2013, about his expectations of the main talking points at the conference in Basel last week. Steve predicted the hottest topics for discussion this year to be Logistics, Planning and Forecasting and looking at ways to improve communication and relationships with stakeholders.

Articles

Video

PDF

  • Are There Any Markets Left to Emerge?Are There Any Markets Left to Emerge?
    When it comes to clinical research, an already small world continues to grow even smaller. In no area is this more evident than site selection for clinical trials.Companies have thus turned to new global locations to run trials – an effort made far easier due to the huge improvements that emerging markets have made in investigator and patient identification, as well as regulatory initiatives. In fact, some say that all feasible emerging markets have already emerged, and that there are no other new markets where entry makes sense.

  • Clinical Trial Supply & Logistics Insights 2014 -Interactive vBook  Clinical Trial Supply & Logistics Insights 2014 -Interactive vBook

    In this new Clinical Trial Supply &Logistics Insights 2014 Interactive vBook, Cold Chain IQ brings you 5 video insights from experts in the field. In this easily digestible interactive video eBook, find out how your peers are overcoming the greatest challenges and mitigating risk in the clinical supply chain.

Regulations for Global Supply

Video

Articles

  • Talking Heads: 7 Growing Trends in Clinical Trial SupplyTalking Heads: 7 Growing Trends in Clinical Trial Supply

    Pharma IQ had a quick ring around with some of our trusted experts who are working in clinical trials to get an overview on current and emerging trends in clinical trial supply. This panel of experts included, Robert Bronstein, Director - Clinical Supply Operations, MacroGenics; Robert Smith, Clinical Trials Expert and Steven A. Jacobs, MBA, R.Ph.President, Global BioPharm Solutions, LLC.